Why national consumption of direct oral anticoagulants over the rise of COVID-19 pandemic exceeded all potential recommendations: A qualitative analysis of textual details of Russian clinical practice guidelines
International Journal of Risk & Safety in Medicine · 2025
DOI: 10.1177/09246479251401348 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Risk & Safety in Medicine, 2025. Verfasst von Elena A Baybulatova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Peoples' Friendship University of Russia named after Patrice Lumumba (RUDN University), Moscow, Russia. Hauptthemen laut MEDLINE: COVID-19, Anticoagulants, Practice Guidelines as Topic, COVID-19 Drug Treatment. Die Arbeit nennt 13 Literaturangaben. Gefördert von: Sponsor: Peoples’ Friendship University of Russia named after Patrice Lumumba..
Abstract (Originalsprache)
Background
COVID-19-associated thrombotic complications became a major problem of pandemic. Clinical practice guidelines are meant to present approaches to preventing and managing them. In our previous studies, we found that direct oral anticoagulants (DOACs) consumption and expenditure in Russia through COVID-19 pandemic was extensive, exceeding CPGs’ recommendations in 2020 and 2021, particularly in outpatient settings.
Objective
To analyze Russian clinical practice guidelines on the use of DOACs for COVID-19.
Methods
We conducted thematic content analysis of Russian guidelines using qualitative research methods. Purposive sampling allowed including all existing guidelines on the use of DOACs in COVID-19 pandemic. The sample size was limited to the results of our previous searches of the Russian guideline and bibliographic databases. We focused on indications, contraindications, dosing regimens, monitoring, and drug interactions and compared with international recommendations.
Results
Only one guideline advised against outpatient DOAC use for COVID-19, aligning with international standards. The guidelines lacked clarity on indications, dosing, and treatment duration. Only two of six guidelines included safety monitoring recommendations, while four provided precautions.
Conclusion
We conclude that the found textual problems could potentially cause the established excessive consumption of direct oral anticoagulants in outpatients with COVID-19 on the rise the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peoples' Friendship University of Russia named after Patrice Lumumba (RUDN University), Moscow, Russia.
- State Budgetary Institution of Healthcare of the City of Moscow "City Clinical Hospital No. 24 of the Moscow City Health Department", Moscow, Russia.
- Cochrane Russia at the Russian Medical Academy for Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia.
- Department of Pharmacology, Kazan State Medical University, Kazan, Russia.
Förderung
- Sponsor: Peoples’ Friendship University of Russia named after Patrice Lumumba.
Zitieren
APA
Baybulatova, E. A., Chenkurov, M. S., Zyryanov, S. K., & Ziganshina, L. E. (2025). Why national consumption of direct oral anticoagulants over the rise of COVID-19 pandemic exceeded all potential recommendations: A qualitative analysis of textual details of Russian clinical practice guidelines. International Journal of Risk & Safety in Medicine. https://doi.org/10.1177/09246479251401348
Vancouver
Baybulatova EA, Chenkurov MS, Zyryanov SK, Ziganshina LE. Why national consumption of direct oral anticoagulants over the rise of COVID-19 pandemic exceeded all potential recommendations: A qualitative analysis of textual details of Russian clinical practice guidelines. International Journal of Risk & Safety in Medicine. 2025. doi:10.1177/09246479251401348
BibTeX
@article{Baybulatova2025,
author = {Baybulatova, Elena A and Chenkurov, Mikhail S and Zyryanov, Sergey K and Ziganshina, Liliya E},
title = {Why national consumption of direct oral anticoagulants over the rise of COVID-19 pandemic exceeded all potential recommendations: A qualitative analysis of textual details of Russian clinical practice guidelines},
journal = {International Journal of Risk & Safety in Medicine},
year = {2025},
doi = {10.1177/09246479251401348}
}
EUVIMED